Lipids in Health and Disease

Table 2 Univariable correlations of PCSK9 with lipid profile and lipoprotein subfractions in patients with CAD

From: Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease

Variables	r	P-value
Age (years)	0.006	0.924
BMI (kg/m²)	-0.064	0.287
SBP (mm Hg)	-0.080	0.180
DBP (mm Hg)	-0.034	0.568
Glucose (mmol/L)	0.047	0.434
TC (mg/dl)	0.249	0.000
TG (mg/dl)	0.075	0.213
Non-HDL-C (mg/dl)	0.221	0.000
Apo A-I (g/L)	0.184	0.003
Apo B (g/L)	0.260	0.000
LDL-C (mg/dl)	0.219	0.000
Large LDL-C (mg/dl)	0.089	0.140
Intermediate LDL-C (mg/dl)	0.145	0.015
Small LDL-C (mg/dl)	0.166	0.005
LDL score (% of sd-LDL)	0.120	0.046
Mean LDL size (Å)	-0.104	0.084
HDL-C (mg/dl)	0.149	0.012
Large HDL-C (mg/dl)	0.045	0.476
Intermediate HDL-C (mg/dl)	0.157	0.013
Small HDL-C (mg/dl)	0.124	0.048

Spearman correlation analysis is shown. The bold values indicate statistical significance and are bolded to improve the readability of the table.
BMI: body mass index. SBP: systolic blood pressure. DBP: diastolic blood pressure. TC: total cholesterol. TG: triglycerides. Non-HDL-C: non high-density lipoprotein cholesterol. ApoA-I: apolipoprotein A1. ApoB: apolipoprotein B. LDL-C: low-density lipoprotein-cholesterol. HDL-C: high-density lipoprotein cholesterol.

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com